Truist Lowers Price Target for Boston Scientific to $90
FinanceAdminYahoo Finance RSS7 hours ago

Truist Lowers Price Target for Boston Scientific to $90

Truist has decreased its price target for Boston Scientific Corporation to $90, indicating a shift in market expectations.

  • Truist has revised its price target for Boston Scientific Corporation (BSX) from $92 to $90.
  • This adjustment reflects changes in market conditions and the company's performance outlook.
  • Investors should consider this new target when evaluating their positions in Boston Scientific.

Source: Yahoo Finance RSS

Read original →

Related Articles